The Overactive Bladder (OAB) Therapeutics Market is segmented by Therapy (Anticholinergics, Mirabegron, Neurostimulation, Intravesical Instillation, Others), Disease Type (Idiopathic Overactive Bladder, Neurogenic Overactive Bladder), and Region (North America, Europe, Asia-Pacific, and Rest of the World).
Revolutionizing Comfort: Exploring Innovations in...
The demand for overactive bladder therapeutics is increasing due to the rising prevalence of OAB worldwide. According to the International Continence Society, overactive bladder affects up to 16% of adults over the age of 18. The condition is more common in women than men and increases in prevalence with age. In addition, lifestyle factors such as obesity, smoking, and caffeine intake can...